AD06
AD06 is a SARS-CoV-2 main protease (Mpro) inhibitor with an IC50 of 163.3 nM. AD06 undergoes nucleophilic attack by deprotonated Cys145, thereby blocking viral replication. AD06 inhibits the activity of wild-type SARS-CoV-2 and shows no significant cytotoxicity in mammalian cells. AD06 can be used in studies related to SARS-CoV-2 infection.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C22H32ClN5O5S
- Masse moléculaire:514.04
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
AD06 exhibits moderate antiviral activity against SARS-CoV-2 in Vero E6 cells with an EC50 of 25.58 μM[1].
AD06 does not exhibit notable cytotoxicity in Vero E6 cells, with a CC50 > 100 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Masse moléculaire 514.04
-
Formule C22H32ClN5O5S
-
SMILES
CC(C[C@@H](C(N[C@@H](C[C@@H]1CCNC1=O)C=O)=O)NC([C@H](C(C)C)NC(C2=CSC(Cl)=N2)=O)=O)C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)